Abstract – Background: Many children stand to benefit from being asthma-free for life with primary (i.e., prenatally started) prevention addressing one environmental exposure in a unifaceted (UF) approach or at least two in a multifaceted (MF) approach. We assessed the cost-effectiveness of primary prevention programmes for Dutch children in a decision-analytic framework. Methods A decision-analytic tree model analysing healthcare costs and asthma cases prevented was developed to compare usual care (UC) with two UF and three MF programmes on the primary prevention of asthma amongst children. Programmes were evaluated through incremental cost-effectiveness ratios and net monetary benefits. Decision and parameter uncertainty were subjected to value-of-information analyses. Results:The current UC and one of three MF programmes dominated the other alternatives. The MF programme was more costly but also more effective than UC at an incremental cost-effectiveness ratio of €8,209.20/additional asthma case prevented. The value of perfect information to reduce uncertainty was €291.6M at its lowest. Most of the uncertainty in the cost-effectiveness threshold was attributable to the probability and cost estimates for low-risk children. Conclusion: This study supports the feasibility of a structured programme that simultaneously addresses exposure to house dust mites, pet dander, environmental tobacco, and breast-feeding as a cost-effective alternative to UC in the primary prevention of asthma amongst children. G. Feljandro P. Ramos, Antoinette D. I. van Asselt, Sandra Kuiper, Johan L. Severens, Tanja Maas, Edward Dompeling, J. André Knottnerus, Onno C. P. van SchayckCost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model. The European Journal of Health Economics October 2013.
- Reducing the use of OCS in asthma management
- Elevated Testosterone May Lower Asthma Risk in Women — Study findings suggest a role for the sex hormone in adult asthma
- The burden of asthma in an inner-city area: A historical review 10 years after Isaac
- A comparison of tiotropium, long-acting β2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma
- Breathe Easier: Expert Q&A on Clinical Challenges in Asthma